What is the current annual D&A of BSX?

As of today, BSX annual D&A is $1.37B

What is 1-year change in BSX annual D&A?

BSX annual D&A is up +7.80% year-over-year

What is 3-year change in BSX annual D&A?

BSX annual D&A is up +20.42% over the past 3 years

How far is BSX annual D&A from its all-time high?

BSX annual D&A is currently at its all-time high

How does BSX annual D&A rank versus sector peers?

BSX annual D&A is higher than 97.59% of companies in Healthcare sector

When is BSX next annual earnings release?

As of today, the next annual earnings release for BSX has not been scheduled

What is the current quarterly D&A of BSX?

As of today, BSX quarterly D&A is $355.00M

What is BSX quarterly D&A most recent change?

BSX quarterly D&A was up +1.14% on June 30, 2026

What is 1-year change in BSX quarterly D&A?

BSX quarterly D&A is up +5.65% year-over-year

How far is BSX quarterly D&A from its all-time high?

BSX quarterly D&A is currently -2.74% below its historical high of $365.00M set on December 31, 2025

How does BSX quarterly D&A rank versus sector peers?

BSX quarterly D&A is higher than 97.51% of companies in Healthcare sector

When is BSX next earnings release?

The next earnings release for BSX is on October 28, 2026

What is the current TTM D&A of BSX?

As of today, BSX TTM D&A is $1.41B

What is BSX TTM D&A most recent change?

BSX TTM D&A was up +1.36% on June 30, 2026

What is 1-year change in BSX TTM D&A?

BSX TTM D&A is up +7.45% year-over-year

How far is BSX TTM D&A from its all-time high?

BSX TTM D&A is currently at its all-time high

How does BSX TTM D&A rank versus sector peers?

BSX TTM D&A is higher than 97.41% of companies in Healthcare sector

When is BSX next earnings release?

The next earnings release for BSX is on October 28, 2026

BSX Depreciation And Amortization History & Chart Since 1991

Annual D&A

$1.37B$99.00M+7.80%

December 31, 2025

Summary

Current Value: As of today, BSX annual D&A is $1.37B, up +7.80% on December 31, 2025
Historical Performance: BSX annual D&A is up +20.42% over the past 3 years, up +21.82% over the past 5 years
All-Time High Comparison: BSX annual D&A is currently at its all-time high
3-Year Low Comparison: BSX annual D&A is +20.42% above its 3-year low of $1.14B reached on an earlier date
Sector Comparison: BSX annual D&A is higher than 97.59% of companies in Healthcare sector

Depreciation & Amortization Chart

beforeafter

Performance

BSX Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual D&A	Dec 31, 25	$1.37B	+7.8%	+20.4%	+21.8%	+67.7%
Quarterly D&A	Jun 30, 26	$355.00M	+5.7%	+19.1%	+35.0%	–
TTM D&A	Jun 30, 26	$1.41B	+7.5%	+21.7%	+28.2%	–
Price	Aug 13, 26	$51.69	-49.6%	+1.3%	+16.6%	+706.4%
Annual SG&A	Dec 31, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Annual Total Expenses	Dec 31, 25	$17.19B	+15.4%	+43.4%	+72.0%	+93.8%
Annual Operating Expenses	Dec 31, 25	$9.88B	+29.5%	+67.8%	+98.6%	+166.1%
Annual Revenue	Dec 31, 25	$20.07B	+19.9%	+58.3%	+102.5%	+157.2%

Depreciation & Amortization Highs

BSX Annual D&A Highs Comparison
Period	High	Date	Current
3Y	$1.37B	Dec 31, 25	at high
5Y	$1.37B	Dec 31, 25	at high
All	$1.37B	Dec 31, 25	at high

Depreciation & Amortization Lows

BSX Annual D&A Lows Comparison
Period	Low	Date	Current
3Y	$1.14B	N/A	+20.4%
5Y	$1.09B	Dec 31, 21	+25.2%
All	$3.40M	Dec 31, 91	>+9999.0%

Depreciation & Amortization History

Year	Value	Change
2025	$1.37B	+7.8%
2024	$1.27B	+6.1%
2023	$1.20B	+5.3%
2022	$1.14B	+3.9%
2021	$1.09B	-2.7%
2020	$1.12B	+11.1%
2019	$1.01B	+13.1%
2018	$894.00M	+5.9%
2017	$844.00M	+3.6%
2016	$815.00M	+6.0%
2015	$769.00M	+6.1%
2014	$725.00M	+5.2%
2013	$689.00M	+0.9%
2012	$683.00M	-4.7%
2011	$717.00M	-12.1%
2010	$816.00M	-2.2%
2009	$834.00M	-3.5%
2008	$864.00M	-8.0%

Year	Value	Change
2007	$939.00M	+20.2%
2006	$781.00M	+148.7%
2005	$314.00M	+14.2%
2004	$275.00M	+40.3%
2003	$196.00M	+21.7%
2002	$161.00M	-30.6%
2001	$232.00M	+28.2%
2000	$181.00M	+1.7%
1999	$178.00M	+38.4%
1998	$128.61M	+48.3%
1997	$86.69M	+41.2%
1996	$61.40M	+55.4%
1995	$39.51M	+334.1%
1994	$9.10M	+43.0%
1993	$6.37M	+38.7%
1992	$4.59M	+35.0%
1991	$3.40M	-

FAQ

What is the current annual D&A of BSX?: As of today, BSX annual D&A is $1.37B
What is 1-year change in BSX annual D&A?: BSX annual D&A is up +7.80% year-over-year
What is 3-year change in BSX annual D&A?: BSX annual D&A is up +20.42% over the past 3 years
How far is BSX annual D&A from its all-time high?: BSX annual D&A is currently at its all-time high
How does BSX annual D&A rank versus sector peers?: BSX annual D&A is higher than 97.59% of companies in Healthcare sector
When is BSX next annual earnings release?: As of today, the next annual earnings release for BSX has not been scheduled

Quarterly D&A

$355.00M$4.00M+1.14%

June 30, 2026

Summary

Current Value: As of today, BSX quarterly D&A is $355.00M, up +1.14% on June 30, 2026
Historical Performance: BSX quarterly D&A is up +5.65% year-over-year, up +19.13% over the past 3 years
All-Time High Comparison: BSX quarterly D&A is currently -2.74% below its historical high of $365.00M set on December 31, 2025
3-Year Low Comparison: BSX quarterly D&A is +19.13% above its 3-year low of $298.00M reached on an earlier date
Sector Comparison: BSX quarterly D&A is higher than 97.51% of companies in Healthcare sector

Performance

BSX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly D&A	Jun 30, 26	$355.00M	+1.1%	+5.7%	+19.1%	+35.0%
Annual D&A	Dec 31, 25	$1.37B	–	+7.8%	+20.4%	+21.8%
TTM D&A	Jun 30, 26	$1.41B	+1.4%	+7.5%	+21.7%	+28.2%
Price	Aug 13, 26	$51.69	-2.6%	-49.6%	+1.3%	+16.6%
Quarterly SG&A	Jun 30, 26	$1.80B	+1.2%	+5.1%	+33.2%	+60.8%
Quarterly Total Expenses	Jun 30, 26	$4.54B	+17.4%	+6.4%	+36.2%	+56.9%
Quarterly Operating Expenses	Jun 30, 26	$2.37B	+2.6%	+5.0%	+37.3%	+65.5%
Quarterly Revenue	Jun 30, 26	$5.44B	+4.6%	+7.5%	+51.2%	+76.9%

Quarterly D&A Highs

BSX Quarterly D&A Highs Comparison
Period	High	Date	Current
1Y	$365.00M	Dec 31, 25	-2.7%
3Y	$365.00M	Dec 31, 25	-2.7%
5Y	$365.00M	Dec 31, 25	-2.7%
All	$365.00M	Dec 31, 25	-2.7%

Quarterly D&A Lows

BSX Quarterly D&A Lows Comparison
Period	Low	Date	Current
1Y	$336.00M	N/A	+5.7%
3Y	$298.00M	N/A	+19.1%
5Y	$263.00M	N/A	+35.0%
All	-$75.00M	Sep 30, 01	+573.3%

Quarterly D&A History

Month	Value	Change
Jun 2026	$355.00M	+1.1%
Mar 2026	$351.00M	-3.8%
Dec 2025	$365.00M	+6.7%
Sep 2025	$342.00M	+1.8%
Jun 2025	$336.00M	+3.4%
Mar 2025	$325.00M	-6.6%
Dec 2024	$348.00M	+13.7%
Sep 2024	$306.00M	-1.6%
Jun 2024	$311.00M	+2.3%
Mar 2024	$304.00M	-2.9%
Dec 2023	$313.00M	+4.3%
Sep 2023	$300.00M	+0.7%
Jun 2023	$298.00M	+4.6%
Mar 2023	$285.00M	-3.1%
Dec 2022	$294.00M	+3.5%
Sep 2022	$284.00M	0.0%
Jun 2022	$284.00M	+3.6%
Mar 2022	$274.00M	-5.5%
Dec 2021	$290.00M	+6.6%
Sep 2021	$272.00M	+3.4%
Jun 2021	$263.00M	-1.9%
Mar 2021	$268.00M	-7.3%
Dec 2020	$289.00M	+2.5%
Sep 2020	$282.00M	+2.5%
Jun 2020	$275.00M	-0.7%

Month	Value	Change
Mar 2020	$277.00M	+19.4%
Dec 2001	$232.00M	+409.3%
Sep 2001	-$75.00M	-200.0%
Jun 2001	$75.00M	-33.0%
Dec 2000	$112.00M	+387.0%
Sep 2000	$23.00M	0.0%
Jun 2000	$23.00M	0.0%
Mar 2000	$23.00M	-87.1%
Dec 1999	$178.00M	+487.0%
Sep 1999	-$46.00M	-300.0%
Jun 1999	$23.00M	0.0%
Mar 1999	$23.00M	-77.5%
Dec 1998	$102.00M	+827.3%
Sep 1998	$11.00M	+37.5%
Jun 1998	$8.00M	0.0%
Mar 1998	$8.00M	+263.6%
Dec 1993	$2.20M	+57.1%
Sep 1993	$1.40M	0.0%
Jun 1993	$1.40M	0.0%
Mar 1993	$1.40M	+16.7%
Dec 1992	$1.20M	0.0%
Sep 1992	$1.20M	0.0%
Jun 1992	$1.20M	+20.0%
Mar 1992	$1.00M	-

FAQ

What is the current quarterly D&A of BSX?: As of today, BSX quarterly D&A is $355.00M
What is BSX quarterly D&A most recent change?: BSX quarterly D&A was up +1.14% on June 30, 2026
What is 1-year change in BSX quarterly D&A?: BSX quarterly D&A is up +5.65% year-over-year
How far is BSX quarterly D&A from its all-time high?: BSX quarterly D&A is currently -2.74% below its historical high of $365.00M set on December 31, 2025
How does BSX quarterly D&A rank versus sector peers?: BSX quarterly D&A is higher than 97.51% of companies in Healthcare sector
When is BSX next earnings release?: The next earnings release for BSX is on October 28, 2026

TTM D&A

$1.41B$19.00M+1.36%

June 30, 2026

Summary

Current Value: As of today, BSX TTM D&A is $1.41B, up +1.36% on June 30, 2026
Historical Performance: BSX TTM D&A is up +7.45% year-over-year, up +21.71% over the past 3 years
All-Time High Comparison: BSX TTM D&A is currently at its all-time high
3-Year Low Comparison: BSX TTM D&A is +21.71% above its 3-year low of $1.16B reached on an earlier date
Sector Comparison: BSX TTM D&A is higher than 97.41% of companies in Healthcare sector

Performance

BSX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM D&A	Jun 30, 26	$1.41B	+1.4%	+7.5%	+21.7%	+28.2%
Annual D&A	Dec 31, 25	$1.37B	–	+7.8%	+20.4%	+21.8%
Quarterly D&A	Jun 30, 26	$355.00M	+1.1%	+5.7%	+19.1%	+35.0%
Price	Aug 13, 26	$51.69	-2.6%	-49.6%	+1.3%	+16.6%
TTM SG&A	Jun 30, 26	$25.20B	+256.3%	+288.5%	+418.1%	+507.1%
TTM Revenue	Jun 30, 26	$21.00B	+1.9%	+13.5%	+56.7%	+87.5%

TTM D&A Highs

BSX TTM D&A Highs Comparison
Period	High	Date	Current
1Y	$1.41B	Jun 30, 26	at high
3Y	$1.41B	Jun 30, 26	at high
5Y	$1.41B	Jun 30, 26	at high
All	$1.41B	Jun 30, 26	at high

TTM D&A Lows

BSX TTM D&A Lows Comparison
Period	Low	Date	Current
1Y	$1.32B	N/A	+7.5%
3Y	$1.16B	N/A	+21.7%
5Y	$1.09B	Sep 30, 21	+29.4%
All	$1.00M	Mar 31, 92	>+9999.0%

TTM D&A History

Month	Value	Change
Jun 2026	$1.41B	+1.4%
Mar 2026	$1.39B	+1.9%
Dec 2025	$1.37B	+1.3%
Sep 2025	$1.35B	+2.7%
Jun 2025	$1.32B	+1.9%
Mar 2025	$1.29B	+1.7%
Dec 2024	$1.27B	+2.8%
Sep 2024	$1.23B	+0.5%
Jun 2024	$1.23B	+1.1%
Mar 2024	$1.22B	+1.6%
Dec 2023	$1.20B	+1.6%
Sep 2023	$1.18B	+1.4%
Jun 2023	$1.16B	+1.2%
Mar 2023	$1.15B	+1.0%
Dec 2022	$1.14B	+0.4%
Sep 2022	$1.13B	+1.1%
Jun 2022	$1.12B	+1.9%
Mar 2022	$1.10B	+0.5%
Dec 2021	$1.09B	+0.1%
Sep 2021	$1.09B	-0.9%
Jun 2021	$1.10B	-1.1%
Mar 2021	$1.11B	-0.8%
Dec 2020	$1.12B	+34.7%
Sep 2020	$834.00M	+51.1%
Jun 2020	$552.00M	+99.3%

Month	Value	Change
Mar 2020	$277.00M	+19.4%
Dec 2001	$232.00M	+107.1%
Sep 2001	$112.00M	-46.7%
Jun 2001	$210.00M	+16.0%
Dec 2000	$181.00M	-26.7%
Sep 2000	$247.00M	+38.8%
Jun 2000	$178.00M	0.0%
Mar 2000	$178.00M	0.0%
Dec 1999	$178.00M	+74.5%
Sep 1999	$102.00M	-35.8%
Jun 1999	$159.00M	+10.4%
Mar 1999	$144.00M	+11.6%
Dec 1998	$129.00M	+377.8%
Sep 1998	$27.00M	+68.8%
Jun 1998	$16.00M	+100.0%
Mar 1998	$8.00M	+25.0%
Dec 1993	$6.40M	+18.5%
Sep 1993	$5.40M	+3.8%
Jun 1993	$5.20M	+4.0%
Mar 1993	$5.00M	+8.7%
Dec 1992	$4.60M	+35.3%
Sep 1992	$3.40M	+54.5%
Jun 1992	$2.20M	+120.0%
Mar 1992	$1.00M	-

FAQ

What is the current TTM D&A of BSX?: As of today, BSX TTM D&A is $1.41B
What is BSX TTM D&A most recent change?: BSX TTM D&A was up +1.36% on June 30, 2026
What is 1-year change in BSX TTM D&A?: BSX TTM D&A is up +7.45% year-over-year
How far is BSX TTM D&A from its all-time high?: BSX TTM D&A is currently at its all-time high
How does BSX TTM D&A rank versus sector peers?: BSX TTM D&A is higher than 97.41% of companies in Healthcare sector
When is BSX next earnings release?: The next earnings release for BSX is on October 28, 2026

Data Sources & References

BSX Official Website www.bostonscientific.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/885725/000088572526000010/0000885725-26-000010-index.htm
BSX Profile on Yahoo Finance finance.yahoo.com/quote/BSX
BSX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bsx